Las Vegas, NV -- (SBWIRE) -- 12/17/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Vical Incorporated (NASDAQ:VICL), Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL), Five Star Quality Care, Inc. (NYSE:FVE), JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO)
Vical Incorporated (NASDAQ:VICL) managed to keep its fall at -3.33% on above-normal volume of 1.18M shares. The stock settled at $1.01 after floating in a range of $1.01 to $1.05. Its latest price has reached market capitalization of $88.08 million. Its 52-week range has been $1.01 to $4.51. Vical Incorporated engages in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases.
Has VICL Found The Bottom and Ready To Move Up? Find Out Here
Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) traded down on a volume of 1.12 million, higher than its standard daily volume. Shares have dropped-3.19% to $2.43. Over the last twelve months, the stock has lost -3.19% and faced a worst price of $2.40. Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel and small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. Its product development programs include Fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, which is in Phase III clinical trials for the treatment of rheumatoid arthritis; R343, an inhaled SYK inhibitor that is in Phase II clinical trials to treat asthma; R333, a topical dermatological janus kinase (JAK)/SYK inhibitor, which is in Phase II clinical trials for the treatment of discoid lupus erythematosus; and R348, a topical ophthalmic JAK/SYK inhibitor that is in Phase I clinical trials to treat keratoconjunctivitis sicca.
Has RIGL Found The Bottom And Ready To Gain Momentum? Find Out Here
Five Star Quality Care, Inc. (NYSE:FVE) settled 12.53% higher at $5.21 on above-normal volume of 1.10M shares during the last trading day. The stock has its 12-month high at $6.87 and 52-week low price was $4.41. It traded in a range of $5.10 to $5.39 during the last trading day. Five Star Quality Care, Inc. operates and manages senior living communities in the United States. Its senior living communities include independent living communities, assisted living communities, and skilled nursing facilities (SNFs).
Why Should Investors Buy FVE After the Recent Fall? Just Go Here and Find Out
In the last trading session, JA Solar Holdings Co., Ltd. (ADR) (NASDAQ:JASO) was up on low volume, trading at a volume of 1.10M versus its average daily volume of 2.52 million shares. At $8.72, the stock has attained market capitalization of 70.54 million. JA Solar Holdings Co., Ltd., through its subsidiaries, engages in the design, development, production, marketing, and sale of solar power products based on crystalline silicon technologies.
Will JASO Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)